The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes

A Scoping Review

Amanda Mauri, Tarlise N. Townsend, Rebecca Lee Haffajee

ResearchPosted on rand.org Apr 29, 2020Published in: The Milbank Quarterly, Volume 98, Number 1, pages 57–105 (March 2020). doi: 10.1111/1468-0009.12436

  • This scoping review reveals a growing literature on the effects of certain state opioid misuse prevention policies, but persistent gaps in evidence on other prevalent state policies remain.
  • Policymakers interested in reducing the volume and dosage of opioids prescribed and dispensed can consider adopting robust prescription drug monitoring programs with mandatory access provisions and drug supply management policies, such as prior authorization policies for high-risk prescription opioids.
  • Further research should concentrate on potential unintended consequences of opioid misuse prevention policies, differential policy effects across populations, interventions that have not received sufficient evaluation (eg, Good Samaritan laws, naloxone access laws), and patient-related outcomes.
Read More

Topics

Document Details

  • Copyright: Milbank Memorial Fund
  • Publisher: Wiley Periodicals Inc
  • Availability: Non-RAND
  • Year: 2020
  • Pages: 49
  • DOI: https://doi.org/10.7249/pubs
  • Document Number: EP-68141

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.